A Team Of Specialists

doft.jpeg (6895 bytes)

Bernard H. Doft Curriculum Vitae - Go Back

Education:

1964-l967

Cornell University College of Arts and Sciences Ithaca, NY

1967-1971

New York University School of Medicine New York, New York MD Degree

 

Post Doctoral Training:

1971-1972

Internal Medicine Straight Medicine Internship

Barnes Hospital, Washington University School of Medicine
St. Louis, MO

l972-l973

Internal Medicine Residency,

Barnes Hospital, Washington University School of Medicine
St. Louis, MO

l973-l975

Research Associate

National Institutes of Health NHLI and BOB

Bethesda, MD

1975-1978

Ophthalmology Residency

Bascom Palmer Eye Institute

University of Miami School of Medicine

Miami, FL

1978-1979

Retina Vitreous Fellowship

Bascom Palmer Eye Institute

University of Miami School of Medicine

Miami, FL

 

Current Appointments and Positions:

1989-present

Clinical Associate Professor of Epidemiology University of Pittsburgh Graduate School of Public Health Pittsburgh, PA

1999-present

Clinical Professor of Ophthalmology University of Pittsburgh School of Medicine Pittsburgh, PA

 

Membership in Professional and Scientific Societies

l970

Alpha Omega Alpha(Honor Medical Society)

l978

Bascom Palmer Eye Institute Alumni Association

l979

Pittsburgh Ophthalmology Society

l979

American Medical Association

l979

Pennsylvania Medical Society

l979

Allegheny County Medical Society

l980

Fellow, The American Academy of Ophthalmology

l982

The Macula Society

1983

The American Society of Retinal Specialists

1984

The Retina Society

 

Certification and Licensure

Speciality Certification:

1975

Certified by the
American Board of Internal Medicine

l979

Certified by the
American Board of Ophthalmology

Medical Licensure:

 

l972

National Board of Medical Examiners

1979

State of Pennsylvania Board of Medical Examiners

 

Honors

l970

Alpha Omega Alpha (Honor Medical Society)

1983

Appointment to Ophthalmic Steering
Committee, Diabetic Control and
Complications Trial, National
Institutes of Health

1983

Recipient of Robert E. Shoemaker
Research Award, The Pennsylvania
Academy of Ophthalmology

1985

Consultant to National Eye Institute
Vision Research Review Committee
National Institutes of Health

1988

Distinguished Teaching Award
The Outstanding Clinical Instructor
1986, 1987. Awarded by the Ophthalmology
Residents, University of Pittsburgh
School of Medicine

1987-1989

Elected Vice Present
Pittsburgh Ophthalmology Society

1989-1991

Elected President
Pittsburgh Ophthalmology Society

1993

Honor Award
American Academy of Ophthalmology
Scientific and Continuing Education

1995

Presentation of
The Tilles-Weidenthal Lecture
Case Western Reserve University
School of Medicine
Cleveland, Ohio
December 1995

1998-1999

Distinguished Clinical Teaching Award
Department of Ophthalmology
University of Pittsburgh
School of Medicine

1999 to present

The Best Doctors in America 1999
Woodward/White, Inc.
University of Pittsburgh Medical Center
Department of Ophthalmology

1999-2000

Distinguished Clinical Teaching Award
Department of Ophthalmology
University of Pittsburgh
School of Medicine

2005 to present

Who's Who in America
Marquis Publications

2006 to current

Who's Who in Medicine & Healthcare
Marquis Publications

2007-present

Elected to Executive Committee The Retina Society

2007

McCaslin Outstanding Clinical Preceptor of the Year Award
Presented by the Senior Residents
Department of Ophthalmology
University of Pittsburgh
School of Medicine

2009

Listed in Who's Who in the World
Marquis Publications

2011

Elected Secretary
The Retina Society

 

Publications

  1. Doft BH, Messina E, and Redisch W: Quantitation of Some Observations of Surface Microvessels of Man. Microvascular Research 1969; l:266.
  2. Rouen L, Terry E, Doft BH, Clauss R, and Redisch W: Classification and Measurement of Surface Microvessels in Man. Microvascular Research 1972; 4:285.
  3. Frommer PL, and Doft BH, (eds.): Needs and Opportunities for Rehabilitating the Coronary Heart Disease Patient. Department of Health, Education, and Welfare, Publication No. (NIH) 75-750; 1976. Bethesda, Maryland, National Heart and Lung Institute.
  4. Frommer PL, and Doft BH, (eds.): Automated Blood Pressure Measuring Devices for Mass Screening. Department of Health, Education, and Welfare. Publication No. (NIH) 76-929; 1976.Bethesda, Maryland, National Heart and Lung Institute.
  5. Doft BH, Merchant B, Johannessen L, Chaparas SD, and Sher NA: Contrasting Effects of BCG on Spleen and Lymph Node Antibody Responses in Nude and Normal Mice. Journal of Immunology 1976; 117:l638.
  6. Budman DR, Merchant EB, Steinberg AD, Doft BH, Gershwin MD, Lizzio E, and Reeves JP: Increased Spontaneous Activity of Antibody Forming Cells in the Peripheral Blood of Patients with Active SLE. Arthritis and Rheumatism 1977; 20:829.
  7. Doft BH, and Smith JL: Inverse Latent Macro Square Wave Jerks and Downbeat Nystagmus. Neuro-Ophthalmology Update, Smith JL, (editor) New York, Masson Publishing, USA, l977.
  8. Doft BH, Smith JL, and Ugarte TR: Inverse Latent Macro Square Wave Jerks and Downbeat Nystagmus. Tr. Am. Ophthalmol. Soc. 1977; 75:l32.
  9. Doft BH: Cytomegalovirus, Immunity, and the Eye. Neuro-Ophthalmology Update, Smith JL, (editor) New York, Masson Publishing, USA, 1980; 4l7-425
  10. Doft BH, Clarkson JG, Rebell G, and Forster RK: Endogenous Aspergillus Endophthalmitis in Drug Abusers. Archives of Ophthalmology 1980; 98:859-862.
  11. Doft BH: Macular Disease for the Practicing Ophthalmologist. Trans. Pennsylvania Acad. Ophthalmol. and Otolaryngol. 1980; 33:l44-l55.
  12. Doft BH: Diverse Manifestations of Ocular Toxoplasmosis. Neuro-Ophthalmol. Smith JL, (editor) New York, Masson Publishing, USA, l982.
  13. Doft BH and Blankenship GW: Single Versus Multiple Treatment Sessions of Argon Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy. Ophthalmol 1982; 89:772-779.
  14. Doft BH, Burns S, and Elsner A: The Inverse Electro-Oculogram. British Journal of Ophthalmol 1982; 66:379-38l.
  15. Doft BH and Curtin VT: Combined Ocular Infection With Cytomegalovirus and Cryptococcosis. Arch Ophthalmol 1982; l00:l800-l803.
  16. Doft BH and Lipkowitz J: An Operational Model To Study Scleral Buckle Infections. Invest. Ophthalmol. Vis. Sci. 1982; 22:53.
  17. Doft BH: Pars Planitis in Identical Twins. Retina 1983; 3:32-33.
  18. Doft BH: Choroidoretinal Vascular Anastomoses. Archives of Ophthalmology 1983; 101:1053-1054.
  19. Kingsley L, Doft BH, Orchard T, Kuller LH, and Becker DJ: Longterm Metabolic Control and Diabetic Retinopathy in an Adolescent Insulin Dependent Diabetic Cohort. Diabetes 1983; 32:9.
  20. Rubinow A, Doft BH, and Cohen AS: Familial Amyloid Polyneuropathy: Immunocytochemical Identification of Prealbumin in the Vitreous. Arthritis Rheumatism 1983; 26:48.
  21. Doft BH, Lipkowitz J, Kowalski R, and Taylor F: An Operational Model For Scleral Buckle Infection. Retina 1983; 3:212-217.
  22. Wingard L, Doft BH, Weiskopf J, Nilsson-Ehle I: Pharmacokinetics of Amphotericin B after Intravitreal Injection into Eyes of Rabbits. The Pharmacologist 1983; 25:150.
  23. Burns SA, Elsner AE, Lobes LA, and Doft BH: Cone Photopigment Kinetics in Retinal Disease. J. Opt. Soc. Am. 1983;73:1915-1916.
  24. Doft BH, Rubinow A, and Cohen A: Immuno-cytochemical Studies of the Vitreous in Amyloidosis: Identification of Prealbumin as the Amyloidogenic Protein. American Journal of Ophthalmology 1984; 97:296-300.
  25. Doft BH, Kingsley L, Orchard T, Becker D, Drash A, Kuller L: The Association Between Diabetic Control and Early Retinopathy.   Ophthalmology 1984; 9l:763-768.
  26. Baldinger JC, Doft BH, Burns SA, Johnson B, and Van-Putten D: Retinal Toxicity After Amphotericin B Injection. Investigative Ophthalmology and Visual Science 1984; 25:258.
  27. Elsner AE, Burns S, Lobes L, and Doft BH: Concentration of Human Photopigments, Light and Dark Adaptation. Investigative Ophthalmology and Visual Science 1984; 25:311.
  28. Doft BH, and Blankenship GW: Retinopathy Risk Factor Regression After Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy. Ophthalmology 1984; 91:1453-1457.
  29. Kozy D, Doft BH, Lipkowitz J: Nummular Choroidopathy in Thioridizine Toxicity. Retina 1985; 4:253.
  30. Doft BH, Gass JDM: Punctate Outer Retinal Toxoplasmosis. Archives of Ophthalmology 1985; 103:1332.
  31. Doft BH, Weiskopf J, Nillson-Ehle I, Wingard L: Amphotericin Clearance in Vitrectomized Versus Non-Vitrectomized Eyes. Ophthalmology 1985; 92:1601-1605
  32. Striph G, Doft B H, Rabin B, and Johnson B: Retina S Antigen Induced Uveitis-The Efficacy of Cyclosporin and Corticosteroids. Archives of Ophthalmology 1986; 104:114-117.
  33. Doft BH, Gass JDM, Outer Retinal Layer Toxoplasmosis. Graefe's Archive for Clinical and Experimental Ophthalmology. 1986; 224:78-82.
  34. Doft BH: Intentional Retinotomy for Internal Drainage of Subretinal Fluid. Letter to the Editor, Archives of Ophthalmology 1986; 104:807-808.
  35. Doft BH, Machemer R, Clarkson J, Buettner H, Crock J, McCleod D, Michels R, Scott J, Skinner M, Wilson D: Vitrectomy for Vitreous Amyloidosis. Abstract, American Academy of Ophthalmology 1986; Academy Program Issue.
  36. Baldinger J, Doft BH, Burns S, and Johnson B: Retinal Toxicity of Amphotericin B in Vitrectomized Versus Non-Vitrectomized Eyes. British Journal of Ophthalmology 1986; 70:657‑661.
  37. Doft BH, Gass JDM: Outer Retinal Layer Toxoplasmosis. Abstract, Infectious Diseases Digest 1986; 6:6-7.
  38. Doft BH, Gass JDM: Outer Retinal Layer Toxoplasmosis. Abstract, Ophthalmology Digest 1986; 6:3.
  39. D'Antonio JA, Doft BH, Ellis D, Orchard T: Glycemic Control and Early Markers of Diabetic Complications: The Pittsburgh Prospective Insulin Dependent Diabetes Cohort Study. Abstract, Diabetes (Suppl. 1) 1986; 35:104A.
  40. Burns SA, Elsner AE, Lobes LA, and Doft BH: A Psychophysical Technique for Measuring Cone Photopigment Bleaching. Investigative Ophthalmology and Visual Sciences 1987; 28:711-717.
  41. Doft BH, Machemer R, Clarkson J, Buettner H, Crock J, McCleod D, Michels R, Scott J, Skinner M, Wilson D: Vitrectomy for Vitreous Amyloidosis. Ophthalmology 1987; 94:607-611.
  42. Orchard J, Dorman JS, D'Antonio JA, LaPorte RE, Kuller LH, Ellis D, Doft BH, Becker DJ, Drash AL: The Natural History of Diabetes Complications: The Pittsburgh Studies. Proceedings of International Symposium on Epidemiology of Diabetes Mellitus. March 1987; Vol 70: Supplement 2.
  43. Elsner AE, Burns SA, Lobes LA, and Doft BH: Cone Photopigment Bleaching Abnormalities in Diabetes. Investigative Ophthalmology and Visual Sciences 1987; 28:718-724.
  44. Malton ML, Rinkoff JS, Doft BH, Kennerdell JS: Cryptococcal Endophthalmitis and Meningitis Associated with Acute Psychosis and Exudative Retinal Detachment. Letters to the Journal, American Journal of Ophthalmology 1987; 104,#4:438-439.
  45. Kingsley LA, Dorman JS, Doft BH, Orchard TJ, LaPorte RE, Kuller LH, and Drash AL: An Epidemiologic Approach to the Study: The Pittsburgh Diabetic Morbidity and Retinopathy Studies. Diabetes Research and Clinical Practice 1988; 4:99-109.
  46. Doft BH, Machemer R, Clarkson J, Buettner H, Crock J, McCleod D, Michaels R, Scott J, Skinner M, Wilson D: Pars Plana Vitrectomy for Vitreous Amyloidosis. Abstract. Ophthalmology Digest 1988; 2:27-28.
  47. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Preliminary Results. Archives of Ophthalmology 1988; 106:471-479.
  48. The DCCT Research Group: Reliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988; 11;9:725-732.
  49. Krypton Laser for Proliferative Diabetic Retinopathy: The Krypton Argon Regression of Neovascularization Study: A Multicenter Randomized Controlled Clinical Trial. The Journal of Diabetic Complications 1988; 2;4:189-196.
  50. Wingard LB, Zuravleff JJ, Doft BH, Berk L, Rinkoff JS: Intraocular Distribution of Intravitreal Administered Amphotericin B in Normal and Vitrectomized Eyes. Investigative Ophthalmology and Visual Science 1989; 10:2184-2189.
  51. Norris-Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash AL: Contribution of Diabetes Duration Before Puberty to Development of Microvascular Complications in IDDM Subjects. Diabetes Care 1989; 12;10:686-693.
  52. D'Antonio JA, Ellis D, Doft BH, Becker DJ, Drash AL, Kuller LH, Orchard TJ: Diabetes Complications and Glycemic Control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study (PPIDDCo): Status Report After 5 Years of IDDM. Diabetes Care 1989; 12;10:694-670.
  53. Cryotherapy for Retinopathy of Prematurity Cooperative Group, Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Three-Month Outcome. Archives of Ophthalmology 1990; 108:195-204.
  54. Doft BH: Managing Postoperative Bacterial Endophthalmitis. Vitreoretinal Surgery and Technology; July/August 1990 Vol. 2, No. 4. Slack Inc. Publishers.
  55. Doft BH, Donnelly K: A Single Sclerotomy Vitreous Biopsy Technique in Endophthalmitis. Letter to the Editor, Archives of Ophthalmology April 1991; 109:465.
  56. Doft BH, Lobes LA, Rinkoff JS: A Technique To Clear The Anterior Chamber Media To Allow Pars Plana Vitrectomy In Endophthalmitis. Letter to the Editor, Ophthalmology April 1991; 98:412-413.
  57. Doft BH: The Endophthalmitis Vitrectomy Study. Editorial, Archives of Ophthalmology April 1991; 109:487-489.
  58. Doft BH, Barza M: Letter to the Editor In Reply to Dr.'s Haimann, Weiss, and Miller regarding The Endophthalmitis Vitrectomy Study Editorial. Correspondence, Archives of Ophthalmology August 1991; 109:1061.
  59. Rinkoff JS, Doft BH, Lobes LA: Management of Ocular Penetration from Injection of Local Anesthesia Preceding Cataract Surgery. Archives of Ophthalmology; October 1991; 109: 1421-1425.
  60. Doft BH: The Endophthalmitis Vitrectomy Study. Editorial, Archives of Ophthalmology Spanish language edition September-October 1991; 2;5:302-304.
  61. Cryotherapy for Retinopathy of Prematurity Cooperative Group, Incidence and Early Course of Retinopathy of Prematurity. Ophthalmology 1991;98:1628-1640.
  62. Doft BH, Metz DJ, Kelsey SF: Augmentation Laser for Proliferative Diabetic Retinopathy Which Fails to Respond to Initial Panretinal Photocoagulation. Ophthalmology November 1992; 99:1728-1735.
  63. Barza M, Doft BH, Lynch E: Ocular Penetration of Ceftriaxone, Ceftazidime and Vancomycin After Subconjunctival Injection in Humans. Archives of Ophthalmology January 1993; 111:121-126.
  64. Randomized Comparison of Krypton vs. Argon Scatter Photocoagulation for Diabetic Disc Neovascularization. The Krypton Argon Regression Neovascularization Study (KARNS) Study Report Number 1. Ophthalmology 1993; 100:1655-1664.
  65. Doft BH, Barza M, for the Endophthalmitis Vitrectomy Study Group. Ceftazidime or Amikacin: Choice of Intravitreal Antimicrobials in the Treatment of Postoperative Endophthalmitis. Letter to the Editor, Archives of Ophthalmology January 1994; 112:17-18.
  66. Doft BH: Discussion of "Exogenous Endophthalmitis Initially Treated Without Systemic Antibiotics" by Pavan et al. Ophthalmology July 1994; 101:1296-1297.
  67. Doft BH, Kelsey SF, Wisniewski S, Metz DJ, Lobes LA, Rinkoff JS, Davis M, Kassoff A: Treatment of Post Cataract Extraction Endophthalmitis. Retina November 1994; 14:297-304. (ERRATUM Table 3) Retina January 1995; 15:74.
  68. Dhaliwal DK, Kowalski RP, Donahue SP, Doft BH, Karenchak LM: Evaluation of Vitrectomy Machines as a Source of False Positive Culture Contamination in Endophthalmitis American Journal of Ophthalmology January 1995; 119:62-64
  69. The Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: A Randomized Trial of Immediate Vitrectomy and of Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis. Archives of Ophthalmology December 1995; 113:1479-1496.
  70. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF, and the Endophthalmitis Vitrectomy Study Group: The Endophthalmitis Vitrectomy Study: Spectrum and Susceptibilities of Microbiologic Isolates. American Journal of Ophthalmology July 1996; 122:1-17.
  71. Barza M, Doft BH, and Kelsey SF: Reply Letters to the Editor from Haimann MH, Weiss H, and Miller J, and Baker AS, and Durand M: Archives of Ophthalmology 1996; 114:1026-1027.
  72. Kelsey SF, and Doft BH: Reply Letter to the Editor from Flynn HW, and Meredith TA: Archives of Ophthalmology 1996; 114:1028-1029.
  73. Doft BH, Kelsey SF, and Wisniewski SR: Reply Letters to the Editor from LeClaire JE, and Hanscom T. Archives of Ophthalmology 1996; 114:1030.
  74. Doft BH, Barza M: Optimal Management of Postoperative Endophthalmitis and Results of the Endophthalmitis Vitrectomy Study. Current Opinion in Ophthalmology 1996; 7;III:84-94.
  75. The Endophthalmitis Vitrectomy Study Group. Microbiologic Factors and Visual Outcome in the Endophthalmitis Vitrectomy Study. American Journal of Ophthalmology December 1996; 122:830-846.
  76. Doft BH. Managing Infectious Endophthalmitis: Results of the EVS. American Academy of Ophthalmology, Focal Points March 1997; Volume XV No. 3;(Section 3 of 3):1-14.
  77. Wisniewski SR, Hammer ME, Grizzard WS, Kelsey SF, Everett D, Packo KH, Yarian DL, Doft BH, for the Endophthalmitis Vitrectomy Study Group: The Investigation of Hospital Charges Related to the Treatment of Endophthalmitis in the Endophthalmitis Vitrectomy Study. Ophthalmology May 1997; 104:739-745.
  78. Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA, and the Endophthalmitis Vitrectomy Study Group. The Source of Coagulase Negative Staphylococci in the Endophthalmitis Vitrectomy Study. Archives of Ophthalmology 1997; 115:357-361.
  79. Johnson MW, Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC, Wisniewski SR, and the Endophthalmitis Vitrectomy Study Group. The Endophthalmitis Vitrectomy Study: Relationship Between Clinical Presentation and Microbiologic Spectrum. Ophthalmology 1997; 104:261-272.
  80. Barza M, Pavan PR, Doft BH, Wisniewski SR, Wilson LA, Han DP, Kelsey SF, and the EVS Study Group. Evaluation of Microbiological Diagnostic Techniques in Postoperative Endophthalmitis in the EVS. Archives of Ophthalmology 1997;115:1142-1150.
  81. Doft, B.H. The Endophthalmitis Vitrectomy Study. In: Kertes PJ, Conway MD: Clinical Trials in Ophthalmology: A Summary and Practice Guide. Williams & Wilkins, Media PA, 1998;97-111.
  82. Doft BH, Kelsey SK, Wisniewski SR. Additional Procedures after the Initial Vitrectomy or Tap/Biopsy in the Endophthalmitis Vitrectomy Study (EVS). Ophthalmology 1998;105:707-716.
  83. Johnson MW, Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC, Wisniewski SR, and the Endophthalmitis Vitrectomy Study Group. The Endophthalmitis Vitrectomy Study: Relationship Between Clinical Presentation and Microbiologic Spectrum. Abstract; Ophthalmology Digest 1998:8-11.
  84. Han DP, Wisniewski SR, Kelsey SF, Doft BH, Barza M, Pavan PR, and the Endophthalmitis Vitrectomy Study Group. Microbiological Yields and Complication Rates of Vitreous Needle Aspiration Versus Mechanized Vitreous Biopsy in the Endophthalmitis Vitrectomy Study. Retina 1999;19:98-102.
  85. Han DP, Wisniewski SR, Kelsey SF, Doft BH, Barza M, Pavan PR. Reply Letter to the Editor from Stroh EM. Retina 1999; 19:576-578.
  86. Wisniewski, SR, Kelsey, SK, Groer-Fitzgerald S, Doft, BH, and the Endophthalmitis Vitrectomy Study Group. Characteristics After Cataract Extraction or Secondary Lens Implantation Among Patients Screened for the Endophthalmitis Vitrectomy Study. Ophthalmology 2000;107:1274-1282.
  87. Doft BH, Kelsey SF, Wisniewski SR., and the Endophthalmitis Vitrectomy Study Group. Retinal Detachment in the Endophthalmitis Vitrectomy Study. Archives of Ophthalmology 2000;118:1661-1665.
  88. Doft, BH, Wisniewski, SR, Kelsey, SK, Groer-Fitzgerald S,and the Endophthalmitis Vitrectomy Study Group. Diabetes and Postoperative Endophthalmitis in the Endophthalmitis Vitrectomy Study. Archives of Ophthalmology 2001;119:650-656.
  89. Doft, BH. Laser Photocoagulation for Diabetic Retinopathy:A Guide for non Ophthalmologists. Current Concepts in Ophthalmology 2001;9:9-13.
  90. Doft BH, Kelsey SF, and Wisniewski SR, Barza M. Reply letter to the editor from Enzenauer RW, and Biderman M. “Retinal Detachment in the Endophthalmitis Vitrectomy Study”. Archives of Ophthalmology 2002;120:230-231.
  91. Doft BH, Kelsey SF, and Wisniewski SR, Groer-Fitzgerald S. Reply letter to the editor from Enzenauer RW. “Diabetes and Postoperative Endophthalmitis in the Endophthalmitis Vitrectomy Study”. Archives of Ophthalmology 2002:120:231-233.
  92. Doft BH, Wisniewski, SR, Kelsey, SK, Groer-Fitzgerald S,and the Endophthalmitis Vitrectomy Study Group. Update on the Endophthalmitis Vitrectomy Study: Diabetes and Post Cataract Extraction Endophthalmitis. Retina and Vitreous Disorders. Current Opinion in Ophthalmology 2002:13:147-151.
  93. Doft BH, and the Endophthalmitis Vitrectomy Study Group. The Endophthalmitis Vitrectomy Study. American Journal of Ophthalmology ajo.com Clinical Trials Digest. September 2003 http://www.ajo.com
  94. Doft BH, Barza M. Macular infarction after intravitreal amikacin. [e-letter] British Journal of Ophthalmology Online. November 2003 http://bjo.bmjjournals.com/cgi/eletters/86/3/359#215
  95. Doft BH, Barza M. Macular infarction after intravitreal amikacin. Letter to the Editor in reference to letter by Galloway et al. British Journal of Ophthalmology. 2004;88:850.
  96. Doft BH, Barza M. Post Cataract Extraction Endophthalmitis and the Endophthalmitis Vitrectomy Study. Comprehensive Ophthalmology Update. September-October 2004;5:233-347.
  97. Doft BH. Keeping your eyes alive. Platform Tennis September 2006;8:20-21.
  98. Doft BH. Treatment of Post Cataract Extraction Endophthalmitis: A Summary of the Results from the Endophthalmitis Vitrectomy Study. Archives of Ophthalmology. April 2008;126:554-556.
  99. Ho LY, Doft BH, Wang L, Bunker CH. Clinical predictors and outcomes of pars plana vitrectomy for retained lens material after cataract extraction. American Journal of Ophthalmology, April 2009;147:587-594.
  100. Doft, BH, Acknowledgement of a Seminal Publication. Letter to the Editor in reference to letter by Jules L. Baum. Archives of Ophthalmology. December 2008; 126 (12):1778.
  101. Nautiyal A, Amescua G, Jameson A, Gradowski JF, Hong FY, Doft BH. Sudden loss of vision: Purtscher retinopathy in multiple myeloma. Canadian Medical Association Journal. November 2009; DOI:10.1503/cmaj.081968
  102. Doft, BH, When should I suspect endophthalmitis in my postoperative cataract patients and what are the treatment options? In: Fekrat S. Curbside Consultation in Retina: 49 Clinical Questions. SLACK Incorporated, Thorofare NJ; 2010:161-164.
  103. Scott I, VanVeldhuisen P, Oden N, Ip M, Blodi B, Doft BH, Elman M, Domalpally A. Baseline Characteristics and Response to Treatment of Participants with HRVO Compared to Participants with BRVO and Participants with CRVO in the SCORE Study. SCORE Study Report 14. In Preparation November 2011